EMD-16512

Single-particle
2.36 Å
EMD-16512
3D View Gallery
Deposition: 23/01/2023
Map released: 06/12/2023
Last modified: 20/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16512
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8c9n summary report (pdf.gz) Map and 8c9n FULL report (pdf.gz)
EMICSS annotations (xml)

MiniCoV-ADDomer, a SARS-CoV-2 epitope presenting viral like particle

EMD-16512

Single-particle
2.36 Å
EMD-16512
3D View Gallery
Deposition: 23/01/2023
Map released: 06/12/2023
Last modified: 20/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human adenovirus B3
Sample: ADDomer Mini-COVID viral like particle vaccine derived from Human Ad3 penton base protein.
Fitted models: 8c9n

Deposition Authors: Bufton JC, Capin J, Boruku U, Garzoni F, Schaffitzel C, Berger I
In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2.
Buzas D, Bunzel AH, Staufer O, Milodowski EJ, Edmunds GL , Bufton JC, Vidana Mateo BV, Yadav SKN, Gupta K , Fletcher C, Williamson MK, Harrison A, Borucu U, Capin J, Francis O, Balchin G, Hall S, Vega MV, Durbesson F, Lingappa S, Vincentelli R, Roe J, Wooldridge L , Burt R, Anderson RJL , Mulholland AJ , Hare J, Bailey M , Davidson AD, Finn A, Morgan D , Mann J, Spatz J , Garzoni F, Schaffitzel C, Berger I
(2023) Antib Ther , 6 , 277 - 297
PUBMED: 38075238
DOI: doi:10.1093/abt/tbad024
ISSN: 2516-4236